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Abstract: Curcumin (diferuloylmethane) is a natural bioactive compound with many health-promoting
benefits. However, its poor water solubility and bioavailability has limited curcumin’s biomedical
application. In the present study, we encapsulated curcumin into liposomes, formed from
natural sources (salmon lecithin), and characterized its encapsulation efficiency and release profile.
The proposed natural carriers increased the solubility and the bioavailability of curcumin. In addition,
various physico-chemical properties of the developed soft nanocarriers with and without curcumin were
studied. Nanoliposome-encapsulated curcumin increased the viability and network formation in the
culture of primary cortical neurons and decreased the rate of apoptosis.
Keywords: nanoliposome; polar lipid; curcumin; transfer; primary cortical neurons

1. Introduction
Curcumin (CUR) is a hydrophobic polyphenolic compound derived from the rhizomes of
Curcuma longa [1]. It is a derivative of turmeric, which is used as a natural spice in East Asian
countries. Commercial curcumin consists of a mixture of three curcuminoids diferuloylmethane
(~77%), demethoxycurcumin (~18%), and bisdemethoxycurcumin (~5%) [2] (Figure 1a). Curcumin is
soluble in organic solvents, such as dimethylsulfoxide (DMSO), ethanol, or acetone, but its solubility
in water is poor. In acidic and neutral conditions, the keto form predominates, and curcumin acts
as a potent donor of H-atoms. But, under alkaline conditions (≥pH 8), the enolic form dominates,
and the phenolic group of the molecule serves as an electron donor [3,4] (Figure 1b). Moreover, the data
obtained by Barzegar (2012) suggest that in physiological condition, like inside the cells, where keto
and enolic forms of curcumin are in the equilibrium, both of H-atom and electron transfer mechanisms
are involved in decreasing free radicals [4].
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Figure 1. Chemical structure of curcuminoids (curcumin, demethoxycurcumin, bisdemethoxycurcumin)
bisdemethoxycurcumin) (a) and pH dependent keto- and enol- tautomeric form of curcumin (b).
(a) and pH dependent keto- and enol- tautomeric form of curcumin (b).
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to improve the bioavailability of curcumin [22,23]. For example, the study of oral administration
of liposome encapsulated curcumin in rats done by Takahashi and co-workers, showed high
bioavailability and higher plasma concentration of curcumin [24].
The liposomal form of curcumin appears to be the best formulation to improve the bioavailability
of curcumin in cells [25]. New forms of liposomes coated with propylene glycol, chitosan or protein
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have been developed, which reduce the release rate of curcumin and improve its bioaccessibility by
promoting oral absorption [26–28].
Phospholipids, which are the main constituent of liposomes, are abundantly found in many
tissues including nervous tissues and brain. This facilitates the delivery of liposomal drugs to the
target tissues. Lecithin from salmon head (Salmo salar) contains a high percentage of polyunsaturated
fatty acids (PUFA), such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are
important constituents of neuronal membranes [29,30]. The present study is primarily focused on
the generation and physico-chemical characterizations of nanoliposomes from salmon lecithin as a
carrier for hydrophobic drug, curcumin. Later, as a proof of principle, we studied the effect of the
nanoliposome-encapsulated curcumin on neuronal network development using in vitro model of
primary cortical neurons.
2. Results and Discussion
2.1. Fatty Acid Analyses
Salmon lecithin has higher variety of polyunsaturated fatty acids (PUFA) composition.
Nine PUFAs of omega 3 and omega 6 were detected in salmon lecithin. The most significant
proportions of fatty acids were C22:6 n-3 (28.15%) and C20:5 n-3 (8.83%). C18:1 n-9 and C16:0 were
major monounsaturated and saturated fatty acids, respectively (19.11% and 19.33%). The ratio of
n-3/n-6 was about 10.
2.2. Lipid Classes
The lipid classes of salmon lecithin showed that the phosphatidylcholine was a major class of
phospholipids in salmon lecithin with 42%. Moreover, the percentage of triacylglycerols (TAG) in
lecithin was 31.20 ± 0.4, and the percentage of polar fraction was 67.65 ± 0.9. Moreover, salmon lecithin
contained a small amount of cholesterol, about 1.15 + 0.1%.
2.3. Liposome Size and Electrophoretic Mobility Measurements
The particle sizes of different nanoliposomes were measured immediately after sonication.
The liposome size depends on the viscosity of the material and agitation parameters including
sonication amplitude and time. The size of the nanoliposome also depends on fatty acid composition,
lipid classes, and the surface-active properties of the lecithin [31,32]. The hydrodynamic diameter of
nanoliposome for salmon lecithins was 119.97 ± 0.42 nm, and the polydispersity index was 0.31 ± 0.00.
The size of the curcumin-loaded liposomes (114.37 ± 1.01 nm) was found to be slightly smaller
than the unloaded curcumin liposomes. These, suggested a strong interaction between curcumin
and lecithin that leads to the compaction of the core. Our results are in good agreement with
the previously reported results [33]. Regarding polydispersity index, we observed no significant
variation between curcumin loaded liposomes and unloaded liposomes (Figure 2). Electrophoretic
mobility value was about −3.5 µm·cm/Vs with a relatively high stability, the polar fraction of lecithin
(phosphate residues) had a negative charge. According to the Dynamic light Scatering (DLS) results,
the electrophoretic mobility in salmon lecithins was −3.51 ± 0.11 µm·cm/Vs. Different types of
phospholipids, like phosphatidylserine (PS), phosphatidic acid (PA), phosphatidylglycerol (PG),
phosphatidylinositol (PI), phosphatidylethanolamine (PE), and phosphatidylcholine (PC) were present
in salmon lecithin. Their charge was negative, except for PC and PE, which did not exhibit a net charge
at physiological pH. Therefore, these anionic fractions were probably responsible for the negative
electrophoretic mobility [34]. Nanoliposomes stability measured by particle size at 4 ◦ C and 37 ◦ C over
one month, which showed no significant variation between day 0 and day 30.
The results obtained by Nanosight show clearly that the liposomes were not monodisperses,
thus the spectra were multimodal explaining existence of many population of vesicle in the system,
because the salmon lecithin contained various phospholipids with different types of fatty acids.
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Indeed, the mean diameter of particles obtained by NTA was highly similar to the Z-average values
measured by DLS (Figure 2).

Figure 2. (a) Schematic of the study, demonstrating the nanoliposomes without (left) and with curcumin
(right). (b) Transmission electron microscopic images of salmon nanoliposome before (left) and after
curcumin encapsulation (right). (c) The size distribution of different nanoliposomes obtained from
nanoparticle tracking analysis with the corresponding NTA video frame liposome (left), liposome loaded
curcumin (right) and (d) size distribution from NTA liposome (left), liposome loaded curcumin (right).
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2.5. Membrane Fluidity
2.5. Membrane Fluidity
Membrane fluidity, which reflects the order and dynamics of phospholipid alkyl chains, can
Membrane fluidity, which reflects the order and dynamics of phospholipid alkyl chains, can
affect the drug release profile from liposomes [29]. In fact, the drug leakage to the aqueous solution
affect the drug release profile from liposomes [29]. In fact, the drug leakage to the aqueous solution is
is enhanced by increasing the fluidity of the bilayer. Membrane fluidity depends on lipid composition
enhanced by increasing the fluidity of the bilayer. Membrane fluidity depends on lipid composition of
of nanoliposomes. The presence of saturated FAs increases the packing between phospholipids,
nanoliposomes. The presence of saturated FAs increases the packing between phospholipids, which
which expellees the water in the vicinity of the bilayer surface. On the other hand, unsaturated FAs
expellees the water in the vicinity of the bilayer surface. On the other hand, unsaturated FAs help
help reducing the packing between phospholipids and preserve the level of hydration, thus
reducing the packing between phospholipids and preserve the level of hydration, thus maintaining
maintaining membrane fluidity [44].
membrane fluidity [44].
Nanoliposomes prepared from salmon lecithin had a membrane fluidity of 3.20 ± 0.03 when they
Nanoliposomes prepared from salmon lecithin had a membrane fluidity of 3.20 ± 0.03 when they
contained higher proportion of polyunsaturated fatty acids. The lipid fluidity was expected to
contained higher proportion of polyunsaturated fatty acids. The lipid fluidity was expected to increase
increase the permeant diffusion rate and partitioning tendency, which yielded a possible squaring
the permeant diffusion rate and partitioning tendency, which yielded a possible squaring effect on the
effect on the enhancement factor.
enhancement factor.
In the presence of curcumin, membrane fluidity of liposome decreased (2.83 ± 0.1), which might
In the presence of curcumin, membrane fluidity of liposome decreased (2.83 ± 0.1), which might
be due to its molecular interaction with liposomes bilayer. Because, curcumin is a highly conjugated
be due to its molecular interaction with liposomes bilayer. Because, curcumin is a highly conjugated
and rigid planar molecule, its presence can weaken hydrophobic interactions among acyl chains of
and rigid planar molecule, its presence can weaken hydrophobic interactions among acyl chains of
phospholipids [45]. Curcumin incorporation perturbs the packing characteristics of the phospholipid
phospholipids [45]. Curcumin incorporation perturbs the packing characteristics of the phospholipid
bilayer and enhances the packing density of the hydrocarbon moiety in the lipid bilayer.
bilayer and enhances the packing density of the hydrocarbon moiety in the lipid bilayer.
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Figure 4. In vitro release of different concentrations of encapsulated curcumin from nanoliposome
Figure 4. In vitro release of different concentrations of encapsulated curcumin from nanoliposome
(values reported are mean ± SD; n = 3).
(values reported are mean ± SD; n = 3).
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Figure 5. Curcumin increases the metabolic activity and the formation of neuronal network.
Cortical neurons were incubated at different time-frame with the lecithin (a) or lecithin encapsulated
curcumin (b) with indicated concentrations. Cell metabolic activity was checked by the XTT test. Results are
expressed as normalized over control. (c) Phase contrast images of neuronal network cultures after treatment
with lecithin or encapsulated curcumin at different concentration and immuno-fluorescent images of
network formation from cortical neurons after treatment with curcumin. Data are mean ± standard error
of three separate experiments from cells of different cultures. * p < 0.05, ** p < 0.01, *** p < 0.001.

2.8. Encapsulated Curcumin Prevented Primary Cortical Neurons from Apoptosis
Since curcumin promoted network elaboration and increased cellular metabolic activity,
we studied the effect of encapsulated curcumin treatment on neuronal cell viability. Previous studies
have shown the neuroprotective role of curcumin treatment [52,53]. We therefore undertook the current
studies to determine whether curcumin encapsulated liposomes could protect neurons from apoptosis.
To quantify the frequency of apoptotic cells, the cultures were incubated with FITC-labeled annexin
V after treatment with different concentration of curcumin and were subsequently analyzed by flow
cytometry. Figure 6a–e and in panel Q4 of the density plots (high level of annexin V-FITC) indicate
a decrease in the percentage of apoptotic cells in the curcumin-treated cells compared with controls.
In accordance with previous results, higher concentration of curcumin prevents neuronal apoptosis
significantly compared to control (2.1 folds decrease for 15 µM and 2.7 folds for 20 µM), as was shown
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solvents [54]. Following materials were used in the present study: Curcumin, acetonitrile and diethyl
ether (Sigma-Aldrich, Saint-Quentin Fallavier, France), Boron trifluoride-methanol (BF3 ) (Bellefonte,
PA, USA), Chloroform (VWR-Prolabo, Milan, Italy), Hexane, methanol and formic acid (Carlo-Erba,
Val de Reuil, France), Ammoniac (Merck KGaA, Darmstadt, Germany). All the utilized organic
solvents were analytical grade reagents.
3.1. Fatty Acids Composition
Fatty acid methyl esters (FAMEs) from salmon, soya and rapeseed lecithin were prepared as described
by Ackman (1998) [55]. Then, FAMEs were analyzed using a Shimadzu 2010 gas chromatography
(Shimadzu, Marne-la-Vallée, France) system equipped with a flame-ionization detector. Separation of
FAME was accomplished on a fused silica capillary column (60 m, 0.25 mm i.d. × 0.20 µm film thicknesses,
SPTM2380 Supelco, Bellefonte, PA, USA). Injector and detector temperatures were settled at 250 ◦ C.
The column temperature was fixed initially at 120 ◦ C for 3 min, then raised to 180 ◦ C at a rate of
2 ◦ C min−1 and maintained at 220 ◦ C for 25 min. Individual fatty acids were identified using Standard
mixtures (PUFA1 from a marine source and PUFA2 from a vegetable source; Supelco, Sigma-Aldrich,
Bellefonte, PA, USA). The results were shown as triplicate analyses.
3.2. Lipid Classes
The lipid classes of different fractions of lipid from salmon lecithin were determined by Iatroscan
MK-5 TLC-FID (Iatron Laboratories Inc., Tokyo, Japan). The measurement was performed according
to the protocol described in detail in our previous paper [41]. Two migrations were done to determine
the proportion of neutral and polar lipid fractions. All standards were purchased from Sigma
(Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany). Area percentages of each pic were presented
as the mean value of three repetitions.
3.3. Preparation of Nanoliposomes
One gram of lecithin and 10 mg curcumin were dissolved in ethanol, then a thin lipid film was
formed on the wall of the flask by means of a Rotavapor in evaporating completely the organic solvent
under vacuum, followed by hydration with 49 mL of distilled water and the suspension was agitated
for 5 h under nitrogen. The samples were then sonicated at 40 KHz and 40% of full power for 360 s
(1 s on, 1 s off) to obtain homogeneous solution. Liposome samples were stored in glass bottle in the
dark at 37 ◦ C.
3.4. Liposome Size and Electrophoretic Mobility Measurements
The mean size and electrophoretic mobility of liposomes were measured by dynamic light
scattering (DLS) using a Malvern Zetasizer Nano ZS (Malvern Instruments Ltd., Malvern, UK). Prior to
measuring size and electrophoretic mobility, the samples were diluted (1:200) with ultrapure distilled
water. The size distribution of particle as well as the dispersed particles electrophoretic mobility was
measured to evaluate the surface net charge around droplets. Measurements were made at 25 ◦ C with
a fixed scattering angle of 173◦ , the refractive index (RI) at 1.471 and absorbance at 0.01. The presented
sizes were the z-average mean (dz) for the liposomal hydrodynamic diameter (nm). The measurements
of electrophoretic mobility were performed in standard capillary electrophoresis cells equipped with
gold electrodes at the same temperature. At least three independent measurements were performed
for each condition.
3.5. Nanoparticle Tracking Analysis (NTA)
Vesicles were analyzed using a NanoSight LM10 instrument (NanoSight, Salisbury, UK). For this
analysis, a monochromati laser beam at 405 nm was applied to the dilute suspension of vesicles.
A video of 60 s duration was taken with a frame rate of 30 frames/s, and particle movement was
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analyzed using NTA software (version 2.1, NanoSight, Malvern Instruments Ltd., Malvern, UK).
The NTA software is able to identify and track individual nanoparticles moving under Brownian
motion and relates the velocity of particle movement to a particle size by applying the two dimensional
Stokes-Einstein equation. The range of sizes that can be analyzed by NTA depends on the particle
type, a high refractive index (e.g., colloidal gold) or a low refractive index (e.g., cell-derived vesicles).
Exosomes and microvesicles have a low refractive index, and the smallest detectable size using the
NTA system is approximately 50 nm. NTA post acquisition settings were optimized and kept constant
between samples, and each video was then analyzed to give the mean, mode, and median vesicle size
together with an estimate of the concentration. All experiments were carried out at 1:10,000 dilution
and each measurement was performed in triplicate [56].
3.6. Stability of Nanoliposomes
The nanoliposomes containing curcumin and the control ones were stored in a drying-cupboard
at 37 ◦ C for 30 days. Mean particle size, electrophoretic mobility and polydispersity index of all
formulations were analyzed every three days. The same protocol described previously was used for
each analysis (Sections 2.5 and 2.6).
3.7. Entrapment Efficiency of Curcumin
The percentage of drug incorporated was determined by centrifuging the drug-loaded
nanoliposomes at 9000× g for 15 min to separate the unloaded curcumin crystals from the liposome.
After centrifugation, an aliquot of liposomal dispersion was dissolved in 2 mL of methanol and the
concentration of curcumin was assayed by HPLC at 425 nm after filtration through a membrane filter
(0.2 µm) (Minisart® RC15 Syringe Filters, Sartorius, Germany). The concentration of curcumin was
determined by a reverse-phase HPLC system (Shimadzu, Kyoto, Japan) equipped with a quaternary
pump (LC-20AD), an auto-injector (SIL-20AC HT), a UV-Vis photodiode array detector (UV-Vis PDA,
SPD-M20A, Shimadzu, Marne-la-Vallée, France), a Zorbex SB-C18 column (5 µm, 4.6 mm × 250 mm)
and Labsolution data software (Shimadzu, Marne-la-Vallée, France). Suspension was analyzed in
isocratic mode using methanol (v/v, 5%), acetic acid 2% (v/v, 30%) and acetonitrile (v/v, 65%)
at a flow rate of 0.5 mL·min−1 . Aliquot (20 µL) was injected onto an AlltimaTM [HP C18, 5 µm
(250 × 4.6 mm i.d.) column (GRACE, Deerfield, IL, USA)] at 25 ◦ C. Detection of curcumin was
performed at 425 nm after 8 min and 49 s. The experiments were performed in triplicate.
The encapsulation efficiency (EE) was calculated as:
EE(%) =

Initial drug ( g) − Free drug( g)
× 100.
Initial drug

(1)

3.8. Transmission Electron Microscopy (TEM)
Transmission electron microscopy was employed to observe the structure of nanliposomes and
chitosan-coated liposome with a negative staining method according to the protocol of Colas et al.
(2007) [57]. Briefly, the samples were diluted 25-folds with distilled water to reduce the concentration
of the particles. Same volume of the diluted solution was mixed with an aqueous solution of
ammonium molybdate (2%) as a negative staining agent. Staining was followed by a 3 min wait at
room temperature, and 5 min on a copper mesh coated with carbon, then samples were examined using
a Philips CM20 Transmission Electron Microscope associated with an Olympus TEM CCD camera.
3.9. Membrane Fluidity
Membrane fluidity of all samples was measured by fluorescence anisotropy measurements.
TriMethylAmmonium DiPhenylHexatriene (TMA–DPH) was used as fluorescent probe which is a
compound that contains a cationic TriMethylAmmonium (TMA) substitute that acts as a surface
anchor to improve the localization of the fluorescent probe of membrane interiors, DiPhenylHexatriene
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(DPH). This measurement was carried out according to the method described by Maherani et al. [58].
Briefly, the solution of TMA–DPH (1 mM in ethanol) was added to the liposome suspension to reach
finally a concentration of 4 µM and 0.2 mg/mL for the probe and the lipid, respectively. The mixture
was lightly stirred for at least 1h at ambient conditions and protected from light. Then, 180 µL of
the solution was distributed into each well of a 96-well black microplate. The fluorescent probe was
vertically and horizontally oriented in the lipid bilayer. The fluorescent intensity of the samples
was measured with Tescan INFINITE 200R PRO (Austria) equipped with fluorescent polarizers.
Samples were excited at 360 nm and emission was recorded at 430 nm under constant stirring at 25 ◦ C.
The Magellan 7 software (Tecan group Ltd., Männedorf, Switzerland), was used for data analysis.
The polarization value (P) of TMA–DPH was calculated using the following equation:
P=

III − GI⊥
,
III + 2GI⊥

(2)

where III is the fluorescent intensity parallel to the excitation plane, I⊥ the fluorescent intensity
perpendicular to the excitation plane, and G is the factor that accounts for transmission efficiency.
Membrane fluidity is defined as 1/P. The results were presented as triplicate analyses.
3.10. In Vitro Drug Release
The percentage of curcumin released was determined as described earlier with suitable
modification [59]. The 2% (w/v) solution of liposomes containing curcumin was dispersed in
PBS (pH 7.4) at a ratio of 1:2. The dispersion was divided into 24 aliquots (1.8 mL each) in 2 mL
Eppendorf tubes and they were kept at 37 ◦ C. Due to low solubility of curcumin in aqueous solutions,
released curcumin were forming crystals. At predetermined time intervals, the sample was centrifuged
also at 9000× g for 10 min to separate the released curcumin crystals from the liposomal dispersion.
After centrifugation, the concentration of curcumin was measured using a HPLC as described
previously. The percentage of released curcumin was determined using the following equation.
Drug release(%) =

Curcumin released (mg/mL)
× 100,
Curcumin encapsulated (mg/mL)

(3)

3.11. Quantification of Curcumin in Nanoliposomes
For in vitro quantification of curcumin, a standard solution of curcumin in methanol was prepared
by adding 5 mg of curcumin into 1 mL of methanol solution. A serial dilution from 2 to 20 µg·mL−1
was done and examined at 425 nm using a UV spectrophotometer (Shimadzu UV-1605, Marne-la-Vallée,
France) and an HPLC. The readings were drawn to generate a calibration curve to quantify the amount
of drug in the nanoliposomes.
3.12. Embryonic Cortical Neurons Cell Culture
Primary cortical neurons were isolated from E18 Sprague Dawley rat embryos. All experiments
were performed in accordance with the guideline established by European Community Council and
were approved by the Italian Ministry of Health. The cortices were harvested in dissociation medium
containing trypsin to digest tissues. Then, cortices were triturated. Neurons were seeded into six-well
tissue culture plates, which were precoated with poly-D-lysine (Sigma, Saint-Quentin Fallavier, France).
Neurons were maintained in Neurobasal Medium (Invitrogen, Carlsbad, CA, USA) supplemented with
B27 (2 mL/100 mL, Invitrogen, Carlsbad, CA, USA), L-glutamine (1 mL/100 mL; Invitrogen, Carlsbad,
CA, USA), and penicillin (50 U/mL)/streptomycin (50 µg/mL) in a 37 ◦ C humidified incubator with a
5% CO2 in air. For biocompatibility test, neurons were directly plated on 96-well plates (15,000 cells
per well) in neurobasal medium containing 2% B27 supplement, 2 mM glutamine and antibiotics.
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3.13. XTT Test
The metabolic activity of the cortical neurons was assessed using the Cell Proliferation Kit II
(XTT, 11 465 015 001, Roche, Mannheim, Germany) as per manufacturers protocol. Five hours after
plating, neurons were treated with curcumin encapsulated nanoliposomes or nanoliposome alone
at 5, 10, 15 and 20 µM concentrations or maintained in maintenance medium as non-treated control.
Mitochondrial activity was measured at 3, 5, 7, and 9 days in vitro (DIV).
3.14. Immunofluorescence Assay
Cells were fixed with 4% PFA, 3% sucrose in PBS for 10 min at RT and permeabilized with 0.1%.
Triton X-100 in PBS for 5 min at RT. Samples were blocked for 30 min in IF buffer (3% BSA, 2% goat
serum in PBS). Cells were sequentially incubated with primary and secondary antibodies diluted
in IF buffer (each for one hour at RT). Coverslips were mounted in Mowiol 4-88. Primary antibody
was polyclonal anti-neuronal class III β-tubulin (#T2200, Sigma, Milan, Italy). Fluorescent-conjugated
secondary antibody was from Molecular Probes (Invitrogen, Carlsbad, CA, USA). Images were
acquired at an upright Leica TCS SP5 AOBS TANDEM confocal microscope equipped with a 60X/0.80
APO L W UVI objective (Leica Microsystems, Nanterre, France).
3.15. Flow Cytometry Analysis
Flow cytometry analyses were performed to measure cell apoptosis as previously described [60]
using the annexin V-FITC apoptosis detection kit (#A9210, Sigma, Milan, Italy) following the
manufacturer’s instructions. Primary cortical neurons were washed, briefly trypsinized, then washed
again twice with cold 1× PBS. Harvested cells were then centrifuged and resuspended in 1× binding
buffer. Cells were incubated with staining solution (annexin V-FITC) for 10 min in the dark at 4 ◦ C.
The cells were resuspended in 1× binding buffer before analyzed by flow cytometry. Samples were
kept on ice during the entire procedure. Ten thousand cells from each sample were scanned and
analyzed by FACS Calibur flow cytometry (Becton Dickinson, Franklin Lakes, NJ, USA) using the
standard configuration and parameters. Finally, data acquisition and analysis was performed using
Cell Quest software (Becton Dickinson, Franklin Lakes, NJ, USA).
3.16. Statistical Analysis
All data are presented as mean ± standard error. Analyses were carried out with ‘one-way
ANOVA’ (for three or more groups) with Bonferroni corrections or student t-test (for two groups).
Statistical significance was determined by Student’s t-tests with p values lower than 0.05.
4. Conclusions
The resemblance of liposomes to cellular membrane makes them a suitable carrier for the
transportation of biomolecules through human tissues. The present study reported on the physico-chemical
properties of nanoliposomes with and without curcumin encapsulation. The possibility of using liposomes
as a suitable carrier system for different applications depends on their physico-chemical properties;
fatty acid composition, and preparation methods strongly influence vesicle behavior in biological systems.
In general, particle size and z-potential are the most important properties that determine fate
and stability of liposomes. Knowledge of the z-potential is also useful in controlling the aggregation,
fusion and precipitation of liposomes, which are important factors affecting the stability of liposomal
formulations. The lipid fluidity is expected to increase both the diffusivity and partitioning tendency
of the permeant. Bilayer fluidity also reflects the order and dynamics of phospholipid alkyl chains
in the bilayer and mainly depends on its composition, as liposomes composed of unsaturated lipids
have more fluidity. The drug release characteristics exhibited controlled curcumins delivery for longer
duration, which may improve bioavailability of the curcumins in its active, native form.
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The results showed that salmon lecithin includes a wide range of fatty acids and specifically
unsaturated ones EPA and DHA, which are known for their health benefits. From TEM imaging,
we observed that lecithin solutions were largely made of nanoliposomes. Furthermore, the prepared
salmon liposomes were stable for periods more than one month with polydisperse populations which
were confirmed by Nanosight and zetasizer measurement.
Curcumin, a naturally occurring polyphenolic compound has been reported to exhibit several
biological and pharmacological activities such as anti-tumor and anti-cancer properties [61–63].
Accumulating in vitro and in vivo data has shown that curcumin could act as strong candidate for
prevention or treatment of neurodegenerative disorders like Parkinsons, Alzheimer’s, and stroke [64,65].
We previously demonstrated that nanoliposomes act as natural carrier systems have a positive role
in neuronal metabolic activity and network formation. Application of nanoliposome-encapsulated
curcumin in primary cortical neurons, demonstrated the effectiveness of the system in viability and
formation of networks in comparison to untreated or only liposome treated cultures. The decrease in
the apoptosis rate in treated cultures achieved in this study suggests the neuroprotective role of the
engineered curcumin-loaded nanoliposomes. However, this hypothesis should be later tested in vivo and
particularly in animal models of neurodegenerative disorders.
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